Common use

Farxiga (dapagliflozin) is a prescription oral medication belonging to the sodium-glucose co-transporter 2 (SGLT2) inhibitor class, prescribed for the management of type 2 diabetes mellitus in adults. In addition, Farxiga has received expanded indications for reducing the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (with reduced or preserved ejection fraction), and for slowing the progression of chronic kidney disease (CKD). Dapagliflozin works by blocking the SGLT2 protein in the kidneys, which is responsible for reabsorbing the majority of filtered glucose back into the bloodstream. By inhibiting this transporter, Farxiga promotes the excretion of excess glucose through the urine, effectively lowering blood sugar levels through an insulin-independent mechanism. The additional cardiorenal benefits have made Farxiga one of the most versatile medications in modern metabolic and cardiovascular medicine. Buy Farxiga online at DutyPills for affordable dapagliflozin tablets with fast, reliable delivery.

Dosage and direction

Farxiga is usually taken once daily in the morning, with or without food. Swallow the tablet whole with a glass of water; do not crush, cut, or chew. The typical starting dose for type 2 diabetes is 5 mg once daily, which may be increased to 10 mg once daily for patients who require additional glycemic control and who tolerate the lower dose well. For heart failure and chronic kidney disease indications, the recommended dose is typically 10 mg once daily. Dosage adjustments are based on kidney function (eGFR), tolerability, and clinical response. Farxiga is not recommended for initiation in patients with an eGFR below 25 mL/min for the diabetes indication. Regular monitoring of blood glucose, HbA1c, kidney function, and electrolytes is essential during treatment.

Precautions

Before starting Farxiga, inform your doctor if you have chronic kidney disease, liver disease, a history of low blood pressure or volume depletion, recurrent urinary tract infections, genital yeast infections, diabetic ketoacidosis, or peripheral vascular disease. Because dapagliflozin increases urinary glucose excretion, it raises the risk of genital mycotic infections (yeast infections) and urinary tract infections; practice good hygiene and report any symptoms such as itching, burning, or unusual discharge promptly. Stay adequately hydrated throughout the day, particularly during hot weather, vigorous exercise, or illness, to prevent dehydration and orthostatic hypotension. Be aware that Farxiga may cause euglycemic diabetic ketoacidosis (DKA with near-normal blood sugar levels), so watch for symptoms like nausea, vomiting, abdominal pain, excessive fatigue, and difficulty breathing. Temporarily discontinue Farxiga before major surgical procedures or during extended periods of fasting.

Contraindications

Do not use Farxiga if you are allergic to dapagliflozin or any component of the tablet. It is contraindicated in patients with severe renal impairment (eGFR below 25 mL/min for diabetes indication), end-stage renal disease (ESRD), or those currently on dialysis. Farxiga should not be used during pregnancy, as it may cause adverse fetal effects based on animal data, or during breastfeeding unless directed otherwise by your healthcare provider. Patients with type 1 diabetes should not use this medication.

Possible side effect

Common side effects of Farxiga dapagliflozin include genital yeast infections (vulvovaginal candidiasis in women, balanitis and balanoposthitis in men), urinary tract infections, increased urination (polyuria and nocturia), thirst, back pain, constipation, and mild dizziness or lightheadedness when standing. These side effects are generally manageable and often improve with time and supportive care. More serious side effects may include diabetic ketoacidosis (potentially with near-normal glucose levels), acute kidney injury, severe urinary tract infections progressing to pyelonephritis or urosepsis, significant hypotension, hyperkalemia, Fournier’s gangrene (necrotizing fasciitis of the perineum), and severe hypoglycemia when combined with insulin or sulfonylureas. Seek immediate medical attention if you experience any signs of these serious conditions.

Drug interaction

Farxiga may interact with loop and thiazide diuretics (increasing the risk of volume depletion and hypotension), insulin and insulin secretagogues such as sulfonylureas (increasing the risk of hypoglycemia, requiring dose reduction), antihypertensive medications, lithium, digoxin, and UGT1A9 enzyme inducers such as rifampin (which may decrease dapagliflozin efficacy). Inform your healthcare provider about all prescription medications, over-the-counter products, and dietary supplements you are taking.

Missed dose

If you miss your daily dose of Farxiga, take it as soon as you remember on the same day. If it is already the next day, skip the missed dose and resume your regular schedule the following morning. Do not take two tablets on the same day to make up for a missed dose.

Overdose

An overdose of Farxiga may cause significant dehydration, electrolyte imbalances, dangerously low blood sugar (especially when used with other antidiabetic agents), or acute kidney injury. If you suspect an overdose, seek emergency medical attention immediately. Treatment is supportive, focused on fluid replacement, correction of electrolyte disturbances, and monitoring of renal and cardiac function.

Storage

Store Farxiga at room temperature between 20 and 25 degrees Celsius, protected from moisture, heat, and light. Keep the tablets in the original container and out of the reach of children. Do not use after the expiration date printed on the packaging.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.